These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35369298)

  • 1. The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases.
    Ionescu RF; Enache RM; Cretoiu SM; Cretoiu D
    Front Cardiovasc Med; 2022; 9():856901. PubMed ID: 35369298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer.
    Yuan C; Burns MB; Subramanian S; Blekhman R
    mSystems; 2018; 3(3):. PubMed ID: 29795787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interplay between non-coding RNAs and gut microbiota in human health.
    Fardi F; Khasraghi LB; Shahbakhti N; Salami Naseriyan A; Najafi S; Sanaaee S; Alipourfard I; Zamany M; Karamipour S; Jahani M; Majidpoor J; Kalhor K; Talebi M; Aghaei-Zarch SM
    Diabetes Res Clin Pract; 2023 Jul; 201():110739. PubMed ID: 37270071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
    Trøseid M; Andersen GØ; Broch K; Hov JR
    EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating host gene expression via gut microbiome-microRNA interplay to treat human diseases.
    Mody D; Verma V; Rani V
    Crit Rev Microbiol; 2021 Sep; 47(5):596-611. PubMed ID: 34407384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA sensing and regulating microbiota-host crosstalk via diet motivation.
    Fan Y; Qin M; Zhu J; Chen X; Luo J; Chen T; Sun J; Zhang Y; Xi Q
    Crit Rev Food Sci Nutr; 2024; 64(13):4116-4133. PubMed ID: 36287029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and microbiota: Is there a cross talk?
    Rizk M; Tüzmen S
    Drugs Today (Barc); 2020 Mar; 56(3):211-226. PubMed ID: 32282868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases.
    Xu J; Yang Y; Li X; Ding S; Zheng L; Xiong C; Yang Y
    Imeta; 2023 Aug; 2(3):e124. PubMed ID: 38867936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
    Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
    Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions.
    Sarshar M; Scribano D; Ambrosi C; Palamara AT; Masotti A
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of the gut microbiota-miRNA interaction in the host pathophysiology.
    Li M; Chen WD; Wang YD
    Mol Med; 2020 Nov; 26(1):101. PubMed ID: 33160314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.
    Griffin JL; Wang X; Stanley E
    Circ Cardiovasc Genet; 2015 Feb; 8(1):187-91. PubMed ID: 25691688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the gut microbiome by fecal microRNA.
    Liu S; Weiner HL
    Microb Cell; 2016 Mar; 3(4):176-177. PubMed ID: 28357349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs and extracellular vesicles in the gut: new host modulators of the microbiome?
    Du X; Ley R; Buck AH
    Microlife; 2021; 2():uqab010. PubMed ID: 37223256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
    Hsu CN; Hou CY; Hsu WH; Tain YL
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbes in cardiovascular diseases and their potential therapeutic applications.
    Jin L; Shi X; Yang J; Zhao Y; Xue L; Xu L; Cai J
    Protein Cell; 2021 May; 12(5):346-359. PubMed ID: 32989686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.
    Bu J; Wang Z
    Gastroenterol Res Pract; 2018; 2018():6458094. PubMed ID: 29967639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the crosstalk between the gut microbiota and intestinal immune system.
    Sonoyama K; Ohsaka F
    Biosci Microbiota Food Health; 2023; 42(4):222-228. PubMed ID: 37791343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.